Community-driven development of a modified progression-free survival ratio for precision oncology
Andreas Möck(German Cancer Research Center), Anna Lena Illert(University of Freiburg), Christoph E. Heilig(German Cancer Research Center), Elena Busch, Ursula Ehmer(TUM Klinikum), Georg Heß(Johannes Gutenberg University Mainz), Georg Martin Haag(Heidelberg University), Bárbara Hermes(Klinikum im Friedrichshain), Stefan Burdach(University of British Columbia), Albrecht Stenzinger(Heidelberg University), Andrea Forschner(University of Tübingen), Holger Hebart, Marinela Augustin(Nuremberg Hospital), Martin Hoffmann(Klinikum Ludwigshafen), Simone Hettmer(Martin Luther University Halle-Wittenberg), Stefan Gröschel(University of Applied Sciences Worms), Leonidas Apostolidis(Heidelberg University), Peter Horak(German Cancer Research Center), Cornelia Brendel(Philipps University of Marburg), Evelin Schröck(German Cancer Research Center), Johannes Bloehdorn(Universitätsklinikum des Saarlandes), Thomas M. Deutsch, Simon Kreutzfeldt(German Cancer Research Center), Frank Griesinger(Carl von Ossietzky Universität Oldenburg), Richard F. Schlenk(German Cancer Research Center), Mareike Dietrich, Stefan Fuxius(Praxis für Hämatologie und Onkologie), Benedikt Brors(German Cancer Research Center), Jozefina Casuscelli(LMU Klinikum), Alexander Desuki, Christoph Heining(Krankenhaus Dresden-Friedrichstadt), Hanno Glimm(German Cancer Research Center), Daniela Aust(Technische Universität Dresden), Niels Halama(German Cancer Research Center), Manuela A. Hoechstetter(Ludwig-Maximilians-Universität München), Anne Flörcken(Humboldt-Universität zu Berlin), Johanna Falkenhorst(Essen University Hospital), Sabine Grill(TUM Klinikum), Irfan Ahmed Bhatti, Thomas J. Ettrich(Universität Ulm), Jan Braess, Christian Britschgi(University of Bern), Felix J. Hüttner(German Society of Surgery), Tanja Fehm(Düsseldorf University Hospital), Nina Heidger, Maria Gonzales-Carmona, U. Haag(Heidelberg University), Dirk Jäger(German Cancer Research Center), Daniel Hüebschmann(German Cancer Research Center), Stefan Fröhling(German Cancer Research Center)
Cited by 44
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.7k